Correlative Assessment of Hemodynamic Parameters Obtained with T2^*-weighted Perfusion MR Imaging and SPECT in Symptomatic Carotid Artery Occlusion

References

1. ↵
   Derdeyn CP, Powers WJ, Grubb RL Jr. Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol 1998;19:1463-1469

   Abstract
2. Powers WJ, Grubb RL Jr, Raichle ME. Physiological responses to focal cerebral ischemia in humans. Ann Neurol 1984;16:546-552

   CrossRefPubMedWeb of Science
3. ↵
   Gibbs JM, Wise RJ, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1984;11:310-314
4. Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol 1995;16:563-570

   Abstract
5. ↵
   Maeda M, Yuh WTC, Ueda T, et al. Severe occlusive carotid artery disease: hemodynamic assessment by MR perfusion imaging in symptomatic patients. AJNR Am J Neuroradiol 1999;20:43-51

   Abstract/FREE Full Text
6. Kluytmans M, van der Grond J, Viergever MA, et al. Gray matter and white matter perfusion imaging in patients with severe carotid artery lesions. Radiology 1998;209:675-682

   PubMedWeb of Science
7. ↵
   Nighoghossian N, Berthezene Y, Philippone B, Adeleine P, Froment JC, Trouillas P. Hemodynamic parameter assessment with dynamic susceptibility contrast magnetic resonance imaging in unilateral symptomatic internal carotid artery occlusion. Stroke 1996;27:474-479

   Abstract/FREE Full Text
8. ↵
   Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T. Acetazolamide reactivity on ¹²³I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J Cereb Blood Flow Metab 1994;14:763-770

   PubMedWeb of Science
9. ↵
   Isaka Y, Nagano K, Narita M, Ashida K, Imaizumi M. High signal intensity on T2-weighted magnetic resonance imaging and cerebral hemodynamic reserve in carotid occlusive disease. Stroke 1997;28:354-357

   Abstract/FREE Full Text
10. Ostergaard L, Johannsen P, Host-Poulsen P, et al. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H₂O positron emission tomography in humans. J Cereb Blood Flow Metab 1998;18:935-940

    CrossRefPubMedWeb of Science
11. ↵
    Thompson HK, Starmer CF, Whalen RE, McIntosh HD. Indicator transit time considered as a gamma variate. Circ Res 1964;14:502-515

    FREE Full Text
12. ↵
    Benner T, Heiland S, Erb G, Forsting M, Sartor K. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 1997;15:307-317

    CrossRefPubMed
13. Herold S, Brown MM, Frackowiak RS, Mansfield AO, Thomas DJ, Marshall J. Assessment of cerebral haemodynamic reserve: correlation between PET parameters and CO₂ reactivity measured by the intravenous 133 xenon injection technique. J Neurol Neurosurg Psychiatry 1988;51:1045-1050

    Abstract/FREE Full Text
14. Moriwaki H, Matsumoto M, Hashikawa K, et al. Hemodynamic aspect of cerebral watershed infarctions: assessment of perfusion reserve using iodine-123-iodoamphetamine SPECT. J Nucl Med 1997;38:1556-1562

    Abstract/FREE Full Text
15. ↵
    Rapela CE, Green HD. Autoregulation of canine cerebral blood flow. Circ Res 1964;15:1205-1211
16. Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994;25:375-381

    Abstract/FREE Full Text
17. ↵
    Hauge A, Nicolaysen G, Thoresen M. Acute effects of acetazolamide on cerebral blood flow in man. Acta Physiol Scand 1983;117:233-239

    PubMedWeb of Science
18. Cotev S, Lee J, Severinghaus JW. The effects of acetazolamide on cerebral blood flow and cerebral tissue _PCO₂. Anesthesiology 1968;29:471-477

    CrossRefPubMed
19. ↵
    Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K, Mowinckel P. Simultaneous assessment of vasoreactivity using transcranial Doppler ultrasound and cerebral blood flow in healthy subjects. J Cereb Blood Flow Metab 1994;14:974-981

    PubMedWeb of Science
20. Karnik R, Valentin A, Winkler WB, Khaffaf N, Donath P, Slany J. Sex-related differences in acetazolamide-induced cerebral vasomotor reactivity. Stroke 1996;27:56-58

    Abstract/FREE Full Text
21. ↵
    Gückel FJ, Brix G, Schmiedek P, et al. Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. Radiology 1996;201:405-412

    PubMed
22. Nighoghossian N, Berthezene Y, Meyer R, et al. Assessment of cerebrovascular reactivity by dynamic susceptibility contrast-enhanced MR imaging. J Neurol Sci 1997;149:171-176

    CrossRefPubMed
23. Patrella JR, DeCarli C, Dagli M, et al. Assessment of whole-brain vasodilatory capacity with acetazolamide challenge at 1.5 T using dynamic contrast imaging with frequency-shifted burst. AJNR Am J Neuroradiol 1997;18:1153-1161

    Abstract
24. ↵
    Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999;53:251-259

    Abstract/FREE Full Text
25. ↵
    Sorensen AG, Tievsky AL, Ostergaard L, Weisskoff RM, Rosen BR. Contrast agents in functional MR imaging. J Magn Reson Imaging 1997;7:47-55

    PubMedWeb of Science
26. ↵
    Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725

    CrossRefPubMedWeb of Science
27. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736

    CrossRefPubMedWeb of Science
28. ↵
    Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-558

    PubMedWeb of Science